Intimation of appointment of Dr.Yogananda Moolemath (DIN: 02870387) as an Independent Director subject to approval of shareholder, appointment of Mr.P N Vinay (DIN: 00047985) as chairman ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has approved the appointment of Dr. Yogananda Moolemath (DIN: 02870387) as an Independent Director for a 5-year term starting January 1, 2026, subject to shareholder approval. Dr. Yogananda is a European Registered Toxicologist with a PhD and over 30 years of experience in drug discovery and regulatory science, currently serving as Chief Scientific Officer at Vittarthaa Life Sciences. Separately, Dr. S N Vinaya Babu, a Promoter and Non-Executive Non-Independent Director, has stepped down as Chairman and will continue as Vice Chairman. Existing Independent Director Mr. P N Vijay (DIN: 00047985), an investment banker with over 50 years of experience, has been designated as the new Chairman effective December 5, 2025, until October 30, 2027. The company also confirmed that neither appointee is debarred by SEBI or any other authority.
This is a positive governance move for shareholders — the Chair role is moving from a Promoter to an Independent Director, strengthening board independence and oversight. No financial or operational impact expected, though the new Independent Director brings strong pharma R&D expertise to the board.